Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Hisse Senetlerindeki Sıralama #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Hisse Fiyatı
$0.11725176
Son senkronizasyon: 2025-07-14
Piyasa Değeri
$481.50K
Değişim (1 gün)
-0.20%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret PHAXIAM Therapeutics S.A. (PHXM)

Kategori

PHAXIAM Therapeutics S.A. (PHXM) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.12 - 2025-07-01

Gün sonu en düşük fiyat: $130.13 - 2013-05-01
PHAXIAM Therapeutics S.A. için hisse fiyatı geçmişi: 2013 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2025 -93.43%
2024 -61.15%
2023 -4.10%
2022 -78.67%
2021 -73.09%
2020 82.18%
2019 -31.14%
2018 -67.04%
2017 59.44%
2016 -51.03%
2015 -15.90%
2014 158.90%
2013 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$517.18 32.51%
US
$857.76 31.47%
NL
$735.86 7.74%
CH
$1.07K -6.40%
KR
$257.99 13.97%
BE